AYTU Aytu BioScience (AYTU) Announces Exclusive Licence Agreement with Tris Pharma for Tuzistra; Armistice Capital Provides $5M Strategic Investment to Accelerate Tuzistra Growth https://www.streetinsider.com/dr/news.php?id=14783354&gfv=1 Heading to $10/share.
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.